INS and laryngotracheoesophageal cleft: In preclinical models, insulin has been shown to foster LC growth through pathways related to these mechanisms, and clinical outcomes in LC patients receiving insulin therapy have been observed to be worse compared to those using other antidiabetic interventions [5,6].